GlucoMe

Company Overview

Snapshot

Founded in December 2013 by Yiftah Ben Aharon and Dov Moran, GlucoMe operated with 1–10 employees. The company was acquired by CuraLife in January 2021, marking a significant exit in the digital health sector.

Business overview

GlucoMe is a digital health company that provides a comprehensive digital solution for diabetes management. Its core technology includes an algorithm-based decision-support system that analyzes diabetes data to offer treatment recommendations, forming an autonomous healthcare platform. The solution integrates an affordable wireless blood glucose monitor with patented audio connectivity, a mobile app for iOS and Android, a cloud-based Digital Diabetes Clinic for healthcare organizations, and a Control Tower for patient and population data management. GlucoMe serves patients, caregivers, and medical professionals, operating within the digital healthcare, medical decision support, and patient remote monitoring sectors.

Strategic signal

In January 2021, GlucoMe was acquired by CuraLife, leading to the cessation of its independent operations. This acquisition signals a consolidation within the digital diabetes management market, indicating that GlucoMe's technology and solutions were deemed valuable enough to be integrated into a larger entity's offerings, potentially expanding CuraLife's footprint in digital health.

Company Intelligence Q&A

What was a significant corporate milestone for GlucoMe?

GlucoMe was acquired by CuraLife in January 2021, after which it ceased to operate independently.

When did GlucoMe receive CE Mark approval for its diabetes decision support technology?

In June 2019, GlucoMe announced it had received CE Mark approval for its diabetes decision support technology.

What strategic partnership did GlucoMe form in August 2018?

In August 2018, Merck KGaA and GlucoMe partnered to pilot remote, digital diabetes care in Vietnam.

When did GlucoMe launch its digital diabetes care solution in Central America?

In April 2018, GlucoMe and DiaMan announced the market launch of GlucoMe's digital diabetes care solution in Central America.

What international deal did GlucoMe secure in January 2018?

In January 2018, GlucoMe won an Indian deal for its diabetes home-care kit, leading to the adoption of its Digital Diabetes Clinic in India.